Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
38,469,785
-
Share change
-
+846,880
-
Total reported value
-
$422,789,150
-
Put/Call ratio
-
562%
-
Price per share
-
$11.00
-
Number of holders
-
137
-
Value change
-
+$12,996,121
-
Number of buys
-
76
-
Number of sells
-
55
Institutional Holders of SCICLONE PHARMACEUTICALS INC - COM (SCLN) as of Q2 2017
As of 30 Jun 2017,
SCICLONE PHARMACEUTICALS INC - COM (SCLN) was held by
137 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,469,785 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, GLG Partners LP, STATE STREET CORP, TWO SIGMA INVESTMENTS, LP, AQR CAPITAL MANAGEMENT LLC, and NORTHERN TRUST CORP.
This page lists
137
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.